ArticleJournal of cachexia, sarcopenia and muscle2011

The orally active melanocortin-4 receptor antagonist BL-6020/979: a promising candidate for the treatment of cancer cachexia.

R Dallmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.